{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:20:40Z","timestamp":1792794040851,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stockholm County Council","id":[{"id":"https:\/\/ror.org\/02zrae794","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordic Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Amgen, Solna"},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvall Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fredrik and Ingrid Thuring Foundation"},{"DOI":"10.13039\/501100008310","name":"Lisa and Johan Gr\u00f6nberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008310","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary hyperparathyroidism (pHPT) can be associated with potentially reversible cognitive impairment, which is occasionally mistaken for natural ageing and dementia. The aim was to evaluate short-term medical normalization of hypercalcaemia in surgical decision-making for elderly patients with mild cognitive deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with pHPT were included in a prospective observational study. A test panel including the Montreal Cognitive Assessment (MoCA) and validated tools for estimation of psychological status (Hospital Anxiety and Depression Scale, HADS), and muscle strength (timed-stands test, TST) was applied at baseline, after 4 weeks of calcimimetic treatment, and after parathyroidectomy. Mild cognitive impairment was defined by a MoCA score below 26. A longitudinal increase in MoCA score of at least 2 points 6 months after surgery was considered clinically meaningful.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 110 patients who underwent testing, 35 aged 50 years or more were identified to have mild cognitive dysfunction, including 19 who were aged at least 70 years (median MoCA score 23, i.q.r. 21\u201324). Calcimimetic treatment resulted in normalization of calcium levels, and improvements in MoCA and HADS scores, and TST time. Normal MoCA scores (at least 26) were reached in 17 patients by 6 months after surgery, of whom 10 were aged 70 years or older. Long-term increase in MoCA score correlated with the decrease in ionized calcium concentration (r = \u20130.536, P\u2009=\u20090.022). Baseline calcium concentration and improvement in MoCA with calcimimetic treatment were identified as independent predictors of favourable outcome after parathyroidectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Medical normalization of hypercalcaemia can aid in predicting outcome after parathyroidectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjsopen\/zraa029","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T08:34:28Z","timestamp":1615883668000},"source":"Crossref","is-referenced-by-count":13,"title":["Prediction of cognitive response to surgery in elderly patients with primary hyperparathyroidism"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3196-7057","authenticated-orcid":false,"given":"A","family":"Koman","sequence":"first","affiliation":[{"name":"Department of Endocrine Tumours and Sarcoma, Karolinska University Hospital , Stockholm, Sweden"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Br\u00e4nstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Endocrine Tumours and Sarcoma, Karolinska University Hospital , Stockholm, Sweden"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Pernow","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Br\u00e4nstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I -L","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Endocrine Tumours and Sarcoma, Karolinska University Hospital , Stockholm, Sweden"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"2023020208500175800_zraa029-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"key":"2023020208500175800_zraa029-B2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/jc.2007-0600","article-title":"Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity","volume":"93","author":"Siilin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2023020208500175800_zraa029-B3","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2023020208500175800_zraa029-B4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/SLA.0b013e31824dad7d","article-title":"Surgery for primary hyperparathyroidism: are the consensus guidelines being followed?","volume":"255","author":"Yeh","year":"2012","journal-title":"Ann Surg"},{"key":"2023020208500175800_zraa029-B5","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-2819","article-title":"Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism","volume":"95","author":"Wu","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2023020208500175800_zraa029-B6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40520-016-0666-7","article-title":"Parathyroidectomy for primary hyperparathyroidism in the elderly: experience of a single endocrine surgery center","volume":"29(Suppl","author":"Cal\u00f2","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"2023020208500175800_zraa029-B7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/bjs.10739","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism","volume":"105","author":"Bannani","year":"2018","journal-title":"Br J Surg"},{"key":"2023020208500175800_zraa029-B8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/bjs.11319","article-title":"Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy","volume":"106","author":"Koman","year":"2019","journal-title":"Br J Surg"},{"key":"2023020208500175800_zraa029-B9","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1210\/jc.2002-021597","article-title":"The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism","volume":"88","author":"Shoback","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2023020208500175800_zraa029-B10","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2023020208500175800_zraa029-B11","author":"Amgen"},{"key":"2023020208500175800_zraa029-B12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Am Geriatr Soc"},{"key":"2023020208500175800_zraa029-B13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology"},{"key":"2023020208500175800_zraa029-B14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-170203","article-title":"The Montreal cognitive assessment: normative data from a large Swedish population-based cohort","volume":"59","author":"Borland","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"2023020208500175800_zraa029-B15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scand"},{"key":"2023020208500175800_zraa029-B16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(85)90465-6","article-title":"Simple method for measurement of lower extremity muscle strength","volume":"78","author":"Csuka","year":"1985","journal-title":"Am J Med"},{"key":"2023020208500175800_zraa029-B17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/cjn.2016.273","article-title":"Validation of Montreal Cognitive Assessment, MoCA, Alternate French Versions","volume":"43","author":"Nasreddine","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"2023020208500175800_zraa029-B18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcp.2010.04.002","article-title":"Clinical utility of calcimimetics targeting the extracellular calcium-sensing receptor (CaSR)","volume":"80","author":"Brown","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"2023020208500175800_zraa029-B19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1073191116654217","article-title":"Changes in Montreal Cognitive Assessment scores over time","volume":"24","author":"Krishnan","year":"2017","journal-title":"Assessment"},{"key":"2023020208500175800_zraa029-B20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"}],"container-title":["BJS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/5\/2\/zraa029\/49043831\/zraa029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/5\/2\/zraa029\/49043831\/zraa029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T04:04:43Z","timestamp":1675310683000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjsopen\/article\/doi\/10.1093\/bjsopen\/zraa029\/6043734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/bjsopen\/zraa029","relation":{},"ISSN":["2474-9842"],"issn-type":[{"value":"2474-9842","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2020,12,22]]},"article-number":"zraa029"}}